Pricing Log in Create free account

Kyntra Bio Inc (KYNB) vs Polyrizon Ltd. (PLRZ)

Kyntra Bio Inc and Polyrizon Ltd. are both Biotechnology companies. Kyntra Bio Inc and Polyrizon Ltd. are of similar size ($23.7M and $21.7M). Across the 7 metrics below, Polyrizon Ltd. leads on 4 and Kyntra Bio Inc on 3.

Valuation

Metric KYNB PLRZ Biotechnology median
P/E 0.11 — 8.50
P/S 4.25 — 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 16.35 n/m 9.21
Earnings yield 934.02% — (33.15%)
Free cash flow yield (194.02%) 0.00% (25.50%)

Profitability

Metric KYNB PLRZ Biotechnology median
Gross margin 6.28% — 65.16%
Operating margin (1,089.78%) — 0.00%
Net margin 3,967.77% — 0.00%
Free cash flow margin (824.19%) 0.00% 0.00%
Return on equity (157.83%) 0.00% (56.36%)
Return on assets 131.26% 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KYNB PLRZ Biotechnology median
Revenue growth (TTM) (37.15%) — 6.02%
EPS growth (last fiscal year) 478.08% 99.37% 30.26%
Revenue growth, 5-year CAGR (48.42%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric KYNB PLRZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.69 36.37 4.72
Net debt to EBITDA 1.97 2.11 0.96

Dividend

Metric KYNB PLRZ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KYNB PLRZ Biotechnology median
Market cap 21.70m 23.74m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack